🔎 Trials Near Me

Home › Metastatic Cancer › Rhode Island

Metastatic Cancer clinical trials in Rhode Island

9 studies for Metastatic Cancer are looking for participants at sites in Rhode Island.

Cities in Rhode Island

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Women and Infants Hospital, Providence
  • Roger Williams Medical Center, Providence
RecruitingPhase 2
All ages · All sexes · Updated Oct 2, 2026 · NCT05564377

TLR9 Immunotherapy for Peritoneal Carcinomatosis

  • Rhode Island and the Miriam Hospitals (Brown University Health), Providence
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07658196

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

  • Rhode Island Hospital, Providence
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05875168

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

  • Research Site, Providence
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06103864

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Women & Infants Hospital, Providence
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213804

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Lifespan Cancer Institute, Providence
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

A Study of PYX-201 in Advanced Solid Tumors

  • Rhode Island Hospital, Providence
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT05720117

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

  • Brown University Health Cancer Institute, Providence
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06362369

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Providence
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.